- Title
- Management of patients with diffuse intrinsic pontine glioma in Australia and New Zealand: Australian and New Zealand Children's Haematology/Oncology Group position statement
- Creator
- Valvi, Santosh; Manoharan, Neevika; Mateos, Marion K.; Hassall, Timothy E. G.; Ziegler, David S.; McCowage, Geoffrey B.; Dun, Matthew D.; Eisenstat, David D.; Gottardo, Nicholas G.; Hansford, Jordan R.
- Relation
- Medical Journal of Australia Vol. 220, Issue 10, p. 533-538
- Publisher Link
- http://dx.doi.org/10.5694/mja2.52295
- Publisher
- John Wiley & Sons
- Resource Type
- journal article
- Date
- 2024
- Description
- The main mission of the Australian and New Zealand Children's Haematology and Oncology Group (ANZCHOG) is to develop and facilitate local access to the world's leading evidence-based clinical trials for all paediatric cancers, including brain tumours, as soon as practically possible. Diffuse intrinsic pontine gliomas (DIPGs) — a subset of a larger group of tumours now termed diffuse midline glioma, H3K27-altered (DMG) — are paediatric brain cancers with less than 10% survival at two years. In the absence of any proven curative therapies, significant recent advancements have been made in pre-clinical and clinical research, leading many to seek integration of novel therapies early into standard practice. Despite these innovative therapeutic approaches, DIPG remains an incurable disease for which novel surgical, imaging, diagnostic, radiation and systemic therapy approaches are needed.
- Subject
- cancer; childhood diseases; radiation oncology; SDG 3; Sustainable Development Goals
- Identifier
- http://hdl.handle.net/1959.13/1510305
- Identifier
- uon:56379
- Identifier
- ISSN:0025-729X
- Rights
- x
- Language
- eng
- Reviewed
- Hits: 396
- Visitors: 387
- Downloads: 0
| Thumbnail | File | Description | Size | Format |
|---|